Dr. Matthew Miller
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Dr. Matthew Miller
Earlier roles on record: COO at Starling Oncology, Inc. (STLN) until June 16, 2023. Starling Oncology, Inc. reported in an 8-K filed May 22, 2023 that Dr. Matthew Miller was terminated as Chief Operating Officer, effective June 16, 2023.
“In connection with the Company's termination of its Chief Operating Officer, Matthew Miller, M.D., effective June 16, 2023, on May 18, 2023, the Company notified Dr. Miller of his termination from his position as the Chief Operating Officer of the Company.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
2022-03-15–2023-06-16
Company network
Recorded roles and call appearances connecting this person to public companies.
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.